Tussi-12D Interactions
There are 546 drugs known to interact with Tussi-12D (carbetapentane / phenylephrine / pyrilamine), along with 11 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 38 are major, 505 are moderate, and 3 are minor.
- View all 546 medications that may interact with Tussi-12D
- View Tussi-12D alcohol/food interactions (2)
- View Tussi-12D disease interactions (11)
Most frequently checked interactions
View interaction reports for Tussi-12D (carbetapentane / phenylephrine / pyrilamine) and the medicines listed below.
- acyclovir
- Advil (ibuprofen)
- Allegra (fexofenadine)
- Ambien CR (zolpidem)
- amoxicillin
- amoxicillin / clavulanate
- Augmentin (amoxicillin / clavulanate)
- Beano (alpha-d-galactosidase)
- carisoprodol
- Celebrex (celecoxib)
- Cialis (tadalafil)
- ciprofloxacin
- citalopram
- codeine / promethazine
- Concerta (methylphenidate)
- Cymbalta (duloxetine)
- DHEA (dehydroepiandrosterone)
- fexofenadine
- Focalin (dexmethylphenidate)
- GenTeal (ocular lubricant ophthalmic)
- Hytrin (terazosin)
- Intuniv (guanfacine)
- ipratropium
- L-Lysine (lysine)
- lecithin
- Levaquin (levofloxacin)
- melatonin
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Zithromax (azithromycin)
Tussi-12D alcohol/food interactions
There are 2 alcohol/food interactions with Tussi-12D (carbetapentane / phenylephrine / pyrilamine).
Tussi-12D disease interactions
There are 11 disease interactions with Tussi-12D (carbetapentane / phenylephrine / pyrilamine) which include:
- depression
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- BPH
- diabetes
- glaucoma
Report options
More about Tussi-12D (carbetapentane / phenylephrine / pyrilamine)
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
